128 related articles for article (PubMed ID: 9086505)
1. An approach to risk assessment.
Simonsen L; Lund SP; Hass U
Neurotoxicology; 1996; 17(3-4):815-24. PubMed ID: 9086505
[TBL] [Abstract][Full Text] [Related]
2. Surveillance of early neurotoxic dysfunction.
Mergler D; Huel G; Bélanger S; Bowler RM; Truchon G; Drolet D; Ostiguy C
Neurotoxicology; 1996; 17(3-4):803-12. PubMed ID: 9086504
[TBL] [Abstract][Full Text] [Related]
3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
4. Evolution and current status of neurotoxicity risk assessment.
Tilson HA
Drug Metab Rev; 1996; 28(1-2):121-39. PubMed ID: 8744593
[TBL] [Abstract][Full Text] [Related]
5. Assessing the risks of exposures to multiple chemicals with a common mechanism of toxicity: how to cumulate?
Wilkinson CF; Christoph GR; Julien E; Kelley JM; Kronenberg J; McCarthy J; Reiss R
Regul Toxicol Pharmacol; 2000 Feb; 31(1):30-43. PubMed ID: 10715222
[TBL] [Abstract][Full Text] [Related]
6. A critical review of the neurotoxicity of styrene in humans.
Pahwa R; Kalra J
Vet Hum Toxicol; 1993 Dec; 35(6):516-20. PubMed ID: 7980742
[TBL] [Abstract][Full Text] [Related]
7. [Recent prevention strategies and occupational risk analysis: Control Banding and Sobane].
Ghittori S; Ferrari M; Negri S; Serranti P; Sacco P; Biffi R; Imbriani M
G Ital Med Lav Ergon; 2006; 28(1):30-43. PubMed ID: 16705887
[TBL] [Abstract][Full Text] [Related]
8. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
[TBL] [Abstract][Full Text] [Related]
9. New developments in exposure assessment: the impact on the practice of health risk assessment and epidemiological studies.
Nieuwenhuijsen M; Paustenbach D; Duarte-Davidson R
Environ Int; 2006 Dec; 32(8):996-1009. PubMed ID: 16875734
[TBL] [Abstract][Full Text] [Related]
10. Quantitative risk assessment for developmental neurotoxic effects.
Razzaghi M; Kodell R
Risk Anal; 2004 Dec; 24(6):1673-81. PubMed ID: 15660620
[TBL] [Abstract][Full Text] [Related]
11. Styrene toxicity: an ecotoxicological assessment.
Gibbs BF; Mulligan CN
Ecotoxicol Environ Saf; 1997 Dec; 38(3):181-94. PubMed ID: 9469867
[TBL] [Abstract][Full Text] [Related]
12. Company-level, semi-quantitative assessment of occupational styrene exposure when individual data are not available.
Kolstad HA; Sønderskov J; Burstyn I
Ann Occup Hyg; 2005 Mar; 49(2):155-65. PubMed ID: 15734828
[TBL] [Abstract][Full Text] [Related]
13. Food and Drug Administration Proposed Guidelines for Neurotoxicological Testing of Food Chemicals.
Sobotka TJ; Ekelman KB; Slikker W; Raffaele K; Hattan DG
Neurotoxicology; 1996; 17(3-4):825-36. PubMed ID: 9086506
[TBL] [Abstract][Full Text] [Related]
14. Establishing stable test performance in tests from the Behavioral Assessment and Research System (BARS).
Rohlman DS; Bailey SR; Brown M; Blanock M; Anger WK; McCauley L
Neurotoxicology; 2000 Oct; 21(5):715-23. PubMed ID: 11130275
[TBL] [Abstract][Full Text] [Related]
15. Studying toxicants as single chemicals: does this strategy adequately identify neurotoxic risk?
Cory-Slechta DA
Neurotoxicology; 2005 Aug; 26(4):491-510. PubMed ID: 16112317
[TBL] [Abstract][Full Text] [Related]
16. [The concept of risk and its estimation].
Zocchetti C; Della Foglia M; Colombi A
Med Lav; 1996; 87(4):330-47. PubMed ID: 9102559
[TBL] [Abstract][Full Text] [Related]
17. Strategies for the prevention of environmental neurotoxic illness.
Landrigan PJ; Graham DG; Thomas RD
Environ Res; 1993 Apr; 61(1):157-63. PubMed ID: 8472670
[TBL] [Abstract][Full Text] [Related]
18. Lead contamination in Uruguay: the "La Teja" neighborhood case.
Mañay N; Cousillas AZ; Alvarez C; Heller T
Rev Environ Contam Toxicol; 2008; 195():93-115. PubMed ID: 18418955
[TBL] [Abstract][Full Text] [Related]
19. Case-cohort study of styrene exposure and ischemic heart disease.
Matanoski GM; Tao X
Res Rep Health Eff Inst; 2002 May; (108):1-29; discussion 31-7. PubMed ID: 12214600
[TBL] [Abstract][Full Text] [Related]
20. Priority setting for risk assessment--the benefit of human experience.
Alonzo C; Laborde A
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):692-6. PubMed ID: 16153990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
